CONSOLIDATED INCOME STATEMENT - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Net service revenue	$ 556,237	$ 557,988	$ 1,665,594	$ 1,661,135
Cost of service, inclusive of depreciation	311,628	322,227	924,093	943,258
General and administrative expenses:
Salaries and benefits	129,083	125,550	380,926	376,788
Non-cash compensation	6,612	3,495	18,968	15,990
Merger-related expenses	4,980	0	25,151	0
Depreciation and amortization	4,436	5,477	13,604	19,705
Investment impairment	0	3,009	0	3,009
Other	57,287	59,299	180,467	167,851
Total operating expenses	514,026	519,057	1,543,209	1,526,601
Operating income	42,211	38,931	122,385	134,534
Other income (expense):
Interest income	1,304	59	2,452	108
Interest expense	(8,021)	(4,963)	(23,040)	(16,447)
Equity in earnings (loss) from equity method investments	1,252	302	9,366	(442)
Merger termination fee	0	0	(106,000)	0
Miscellaneous, net	1,201	491	5,262	1,155
Total other expense, net	(4,264)	(4,111)	(111,960)	(15,626)
Income before income taxes	37,947	34,820	10,425	118,908
Income tax expense	(12,331)	(9,417)	(40,381)	(32,755)
Net income (loss)	25,616	25,403	(29,956)	86,153
Net loss attributable to noncontrolling interests	344	239	887	739
Net income (loss) attributable to Amedisys, Inc.	$ 25,960	$ 25,642	$ (29,069)	$ 86,892
Basic earnings per common share:
Net income (loss) attributable to Amedisys, Inc. common stockholders	$ 0.80	$ 0.79	$ (0.89)	$ 2.67
Weighted average shares outstanding, basic (shares)	32,624	32,482	32,587	32,519
Diluted earnings per common share:
Net income (loss) attributable to Amedisys, Inc. common stockholders	$ 0.79	$ 0.79	$ (0.89)	$ 2.66
Weighted average shares outstanding, diluted (shares)	32,831	32,616	32,587	32,680